tirzepatide heart racing and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Failure Management Can Tirzepatide Cause Heart Palpitations?

Back GBD 2019 Risk Factor Collaborators (2020) 'Global Burden of 87 Risk Factors in 204 Countries and Territories, 19902019: a systematic analysis for the global burden of disease study 2019', The Lancet , 396, 122349

GFJ significantly reduced the major metabolite of amiodarone [i.e., N -desethylamiodarone, N-desethylamiodarone (N-DEA)] production in all subjects, increasing AUC and Cmax by 50% and 84%, respectively, compared to water administration

Weight regain risk increases if treatment and healthy habits stop abruptly

Always strive to find the most specific J-code available for the medication

Patients rely on compounding pharmacies (licensed by state boards) to safely prepare each dose